On one hand, IBD can lead to dysregulation of adipokines, shifting the balance towards a pro-inflammatory state, on the other hand obesity and higher BMI are associated with higher risk of developing IBD and worse clinical outcomes, particularly for UC
Why Choose OneMedicine
Serious problems are mostly linked to unsupervised use, buying the drug without a prescription, or pushing the dose up too fast
If you practice intermittent fasting, inject during your fasted window
When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm
[1] [2] Common examples include semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda)